Sign inJoin waitlistJoin the waitlist

Mehmet Bilen

Director, Genitourinary Medical Oncology Program · Winship Cancer Institute at Emory Midtown

Credentials: · · · ·

History

Winship Cancer Institute at Emory Midtown
Present
Emory University School of Medicine
Present

Hematology and Medical Oncology
University of Texas M D Anderson Cancer Center
2013–2016
Internal Medicine
Baylor College of Medicine
2008–2011
Hacettepe University Faculty of Medicine
2004–2008

Research

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
The Lancet · 2020 · 1,345 citations
An intra-tumoral niche maintains and differentiates stem-like CD8 T cells
Nature · 2019 · 696 citations
Frailty and cancer: Implications for oncology surgery, medical oncology, and radiation oncology
Review · Current Anthropology · 2017 · 500 citations

Viraj Master
72 papers
Bradley Carthon
57 papers
Omer Kucuk
47 papers
Jacqueline Brown
44 papers · 19 as a fellow
Rana McKay
38 papers · 8 as a resident
BN
Bassel Nazha
36 papers · 7 as a fellow
Vadim Koshkin
34 papers
DM
Dylan Martini
33 papers · 22 as a resident
Kenneth Ogan
32 papers
Shreyas Joshi
30 papers · 1 as a fellow
Petros Grivas
27 papers
Shilpa Gupta
24 papers

Grants

Gut Microbiome and Cancer Immunotherapy Outcomes in Advanced Renal Cell Carcinoma
National Cancer Institute · R01
PI · $3.2M · University of Tx Md Anderson Can Ctr
2022–2027

Clinical trials

Vidutolimod (CMP-001) in Combination With Nivolumab for the Treatment of Metastatic Castration Resistant Prostate Cancer
Principal investigator · Suspended · Phase 2
Emory University
2023–2028
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
Principal investigator · Recruiting · Phase 1
Emory University
2021–2028
Perioperative Lenvatinib With Pembrolizumab in Patients With Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma
Principal investigator · Active not recruiting · Phase 2
Emory University
2020–2026
Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer
Principal investigator · Active not recruiting · Phase 2
Emory University
2019–2026